# YULZETY
> **NDA221033** · New Drug Application · Sponsor: ROSEMONT PHARMS · Approved 2026-10-16
## Drug
- **FDA Application Number:** NDA221033
- **Application type:** New Drug Application
- **Brand name:** YULZETY
- **Generic name:** Rivaroxaban
- **Active ingredients:** RIVAROXABAN
- **Dosage form:** SUSPENSION
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** ROSEMONT PHARMS
- **First approval:** 2026-10-16
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=221033)
---
*MORVS · CC0 1.0*